Healthcare DIVE January 18, 2022
The three test makers said at last week’s J.P. Morgan conference they see opportunities for direct-to-consumer, digitally-connected testing for diseases beyond COVID-19.
The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are hoping to cash in on with over-the-counter and direct-to-consumer testing for other diseases beyond the coronavirus.
The development and adoption of at-home tests that detect coronavirus infection and the integration of digital health technologies are paving the way for broader consumer use of diagnostics for other ailments that don’t have to be performed at a hospital, a physician’s office or a pharmacy.
Abbott CEO Robert Ford said at...